UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

       Date of Report: (Date of earliest event reported) November 14, 2016


                           UNITED CANNABIS CORPORATION
                  -------------------------------------------
                   (Exact name of registrant as specified in
                                    charter)

                                    Colorado
                ------------------------------------------------
         (State or other Jurisdiction of Incorporation or Organization)


                           1600 Broadway, Suite 1600
      000-54582                 Denver, CO 80202               46-5221947
--------------------      ------------------------------     ---------------
   (Commission File       (Address of Principal Executive    (IRS Employer
       Number)                Offices and Zip Code)      Identification Number)


                                 (303) 386-7321
                  -------------------------------------------
              (Registrant's telephone number, including area code)


                                       N/A
              ----------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[ ] Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act
    (17 CFR 240.14a-12(b))

[ ] Pre-commencement  communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement  communications pursuant to Rule 13e-4(c) under the
    Exchange Act (17 CFR 240.13e-4(c))

<PAGE>

ITEM 1.01.  ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

     On December 18, 2014 the Company borrowed  $600,000 from Slainte  Ventures,
LLC. The loan was  evidenced  by a  promissory  note that was due and payable on
December 18, 2016.

     On November 14, 2016 the note was amended such that:

     o    the maturity date of the note was extended to December 30, 2017; and

     o    with the  agreement of the Company,  the note could be converted  into
          shares of the Company's common stock.

     The  number of shares to be issued  upon a  conversion  of the note will be
determined by dividing the dollar amount of the principal to be converted by the
Conversion  Price.  The Conversion  Price is 70% of the average closing price of
the Company's common stock for the ten business days  immediately  preceding the
date of the Conversion.

     On November 16, 2016 Slainte Ventures  converted  $100,000 of the principal
amount of the Note into 72,626 shares of the Company's common stock

ITEM 2.03.  CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN
            OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT.

      See Item 1.01 of this report.

ITEM 3.02.   UNREGISTERED SALES OF EQUITY SECURITIES

     The Company relied upon the exemption from registration provided by Section
4(a)2  of the  Securities  Act of  1933  with  respect  to the  issuance  of the
securities  described  in Item  1.01 of this  report.  The  purchaser  of  these
securities  was  an  accredited  investor  who  was  provided  full  information
regarding  the  Company's   business  and  operations.   There  was  no  general
solicitation  in  connection  with the  offer or sale of these  securities.  The
purchaser  acquired these securities for its own account.  The securities cannot
be sold unless pursuant to an effective  registration  statement or an exemption
from registration.


                                       2

<PAGE>


                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


                                      UNITED CANNABIS CORPORATION


Dated:  November 18, 2016             By:  /s/ Chad Ruby
                                          ------------------------------
                                          Chad Ruby
                                          Chief Operating Officer
[{"type": "8-K", "sequence": "1", "filename": "form8kitem101600koan11-16.txt", "description": "8-K RE SLAINTE $600K LOAN", "secsgml_size_bytes": 4668}]
{"company-data": {"conformed-name": "United Cannabis Corp", "cik": "0001436161", "assigned-sic": "2834", "irs-number": "261391338", "state-of-incorporation": "CO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54582", "film-number": "162007948"}, "business-address": {"street1": "1600 BROADWAY", "street2": "SUITE 1600", "city": "DENVER", "state": "CO", "zip": "80202", "phone": "(407) 432-2547"}, "mail-address": {"street1": "1600 BROADWAY", "street2": "SUITE 1600", "city": "DENVER", "state": "CO", "zip": "80202"}, "former-company": {"former-conformed-name": "MySkin, Inc.", "date-changed": "20080528"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

       Date of Report: (Date of earliest event reported) November 14, 2016

                           UNITED CANNABIS CORPORATION
                  -------------------------------------------
                   (Exact name of registrant as specified in
                                    charter)

                                    Colorado
                ------------------------------------------------
         (State or other Jurisdiction of Incorporation or Organization)

                           1600 Broadway, Suite 1600
      000-54582                 Denver, CO 80202               46-5221947
--------------------      ------------------------------     ---------------
   (Commission File       (Address of Principal Executive    (IRS Employer
       Number)                Offices and Zip Code)      Identification Number)

                                 (303) 386-7321
                  -------------------------------------------
              (Registrant's telephone number, including area code)

                                       N/A
              ----------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[ ] Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act
    (17 CFR 240.14a-12(b))

[ ] Pre-commencement  communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement  communications pursuant to Rule 13e-4(c) under the
    Exchange Act (17 CFR 240.13e-4(c))
ITEM 1.01.  ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

     On December 18, 2014 the Company borrowed  $600,000 from Slainte  Ventures,
LLC. The loan was  evidenced  by a  promissory  note that was due and payable on
December 18, 2016.

     On November 14, 2016 the note was amended such that:

     o    the maturity date of the note was extended to December 30, 2017; and

     o    with the  agreement of the Company,  the note could be converted  into
          shares of the Company's common stock.

     The  number of shares to be issued  upon a  conversion  of the note will be
determined by dividing the dollar amount of the principal to be converted by the
Conversion  Price.  The Conversion  Price is 70% of the average closing price of
the Company's common stock for the ten business days  immediately  preceding the
date of the Conversion.

     On November 16, 2016 Slainte Ventures  converted  $100,000 of the principal
amount of the Note into 72,626 shares of the Company's common stock

ITEM 2.03.  CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN
            OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT.

      See Item 1.01 of this report.

ITEM 3.02.   UNREGISTERED SALES OF EQUITY SECURITIES

     The Company relied upon the exemption from registration provided by Section
4(a)2  of the  Securities  Act of  1933  with  respect  to the  issuance  of the
securities  described  in Item  1.01 of this  report.  The  purchaser  of  these
securities  was  an  accredited  investor  who  was  provided  full  information
regarding  the  Company's   business  and  operations.   There  was  no  general
solicitation  in  connection  with the  offer or sale of these  securities.  The
purchaser  acquired these securities for its own account.  The securities cannot
be sold unless pursuant to an effective  registration  statement or an exemption
from registration.

                                       2
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                      UNITED CANNABIS CORPORATION

Dated:  November 18, 2016             By:  /s/ Chad Ruby
                                          ------------------------------
                                          Chad Ruby
                                          Chief Operating Officer